3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Muscle Weakness
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hypoxia
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Disease
1
Colonic Neoplasms
1
Astrocytoma
1
Anus Neoplasms
1
Interventions
pembrolizumab
15
Cisplatin
7
Cetuximab
5
dostarlimab
3
Surveys and Questionnaires
3
Carboplatin
3
fludarabine
2
abemaciclib
2
Standard of Care
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Nivolumab
2
Interviews as Topic
2
Fulvestrant
2
Docetaxel
2
Cyclophosphamide
2
Blood Specimen Collection
2
130-nm albumin-bound paclitaxel
2
ulixertinib
1
trastuzumab deruxtecan
1
toripalimab
1
tislelizumab
1
ribociclib
1
repotrectinib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
nimotuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Magnetic Resonance Imaging
×
30 days
×
Clear all
No trials found.